ABSTRACT
ABSTRACT Background: Cases of coronavirus disease 2019 (COVID-19) requiring hospitalization continue to appear in vulnerable populations, highlighting the importance of novel treatments. The hyperinflammatory response underlies the severity of the disease, and targeting this pathway may be useful. Herein, we tested whether immunomodulation focusing on interleukin (IL)-6, IL-17, and IL-2, could improve the clinical outcomes of patients admitted with COVID-19. Methods: This multicenter, open-label, prospective, randomized controlled trial was conducted in Brazil. Sixty hospitalized patients with moderate-to-critical COVID-19 received in addition to standard of care (SOC): IL-17 inhibitor (ixekizumab 80 mg SC/week) 1 dose every 4 weeks; low-dose IL-2 (1.5 million IU per day) for 7 days or until discharge; or indirect IL-6 inhibitor (colchicine) orally (0.5 mg) every 8 hours for 3 days, followed by 4 weeks at 0.5 mg 2x/day; or SOC alone. The primary outcome was accessed in the "per protocol" population as the proportion of patients with clinical improvement, defined as a decrease greater or equal to two points on the World Health Organization's (WHO) seven-category ordinal scale by day 28. Results: All treatments were safe, and the efficacy outcomes did not differ significantly from those of SOC. Interestingly, in the colchicine group, all participants had an improvement of greater or equal to two points on the WHO seven-category ordinal scale and no deaths or patient deterioration were observed. Conclusions: Ixekizumab, colchicine, and IL-2 were demonstrated to be safe but ineffective for COVID-19 treatment. These results must be interpreted cautiously because of the limited sample size.
ABSTRACT
ABSTRACT Immune exhaustion and senescence are scarcely studied in HIV-pediatric patients. We studied the circulatory CD8 T cells activation/exhaustion and senescent phenotype of children and adolescents vertically infected with HIV or uninfected controls based on the expression of human leukocyte antigen (HLA-DR), CD38, T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT), programmed death 1 (PD-1) and CD57 by flow cytometry, during approximately one year. Eleven HIV-infected (HI) and nine HIV-uninfected (HU) children/adolescents who received two doses or one dose of meningococcal C conjugate vaccine (MenC), respectively, were involved in this study. Blood samples were collected before the immunization (T0), 1-2 months after the first dose (T1), and 1-2 months after the second dose (T2), which was administered approximately one year after the first one. HI patients not receiving combined antiretroviral therapy (cART) showed a higher frequency of CD8 T cells TIGIT+, PD-1+ or CD57+, as well as a higher frequency of CD8 T cells co-expressing CD38/HLA-DR/TIGIT or CD38/HLA-DR/PD-1 when compared to HI treated or HU individuals, at all times that they were assessed. CD8 T cells co-expressing CD38/DR/TIGIT were inversely correlated with the CD4/CD8 ratio but positively associated with viral load. The co-expression of CD38/DR/TIGIT or CD38/DR/PD-1 on CD8 T cells was also inversely associated with the CD4 T cells expressing co-stimulatory molecules CD127/CD28. The results showed a higher expression of exhaustion/senescence markers on CD8 T cells of untreated HI children/adolescents and its correlations with viral load.
ABSTRACT
ABSTRACT COVID-19 disease is spread worldwide and diagnostic techniques have been studied in order to contain the pandemic. Immunochromatographic (IC) assays are feasible and a low-cost alternative especially in low and middle-income countries, which lack structure to perform certain diagnostic techniques. Here we evaluate the sensitivity and specificity of eleven different IC tests in 145 serum samples from confirmed cases of COVID-19 using RT-PCR and 100 negative serum samples from blood donors collected in February 2019. We also evaluated the cross-reactivity with dengue using 20 serum samples from patients with confirmed diagnosis for dengue collected in early 2019 through four different tests. We found high sensitivity (92%), specificity (100%) and an almost perfect agreement (Kappa 0.92) of IC assay, especially when we evaluated IgG and IgM combined after 10 days from the onset of symptoms with RT-PCR. However, we detected cross-reactivity between dengue and COVID-19 mainly with IgM antibodies (5 to 20% of cross-reaction) and demonstrated the need for better studies about diagnostic techniques for these diseases.
ABSTRACT
ABSTRACT Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged ≥ 60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged ≥ 18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged ≥ 60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Yellow Fever Vaccine/immunology , Yellow fever virus/immunology , Yellow Fever/prevention & control , Age Factors , Brazil , Immunoglobulin M/blood , Yellow Fever/immunologyABSTRACT
Resumo Introdução/Objetivo: Evidências recentes sugerem que anormalidades que envolvem os linfócitos Th17 estão associadas à fisiopatologia do lúpus eritematoso sistêmico (LES). Além disso, os linfócitos T multifuncionais (LTM), ou seja, aqueles que produzem múltiplas citocinas simultaneamente, estão presentes no meio inflamatório e podem estar implicados no processo autoimune observado no LES. No presente estudo, objetiva-se caracterizar o estado funcional dos linfócitos T CD4+ no LES e determinar simultaneamente a concentração de IL-2, IFN-γ e IL-17 em culturas de linfócitos sob estímulos exógenos e autoantigênicos. Pacientes e métodos: Dezoito pacientes com doença ativa, 18 com doença inativa e 14 controles saudáveis foram submetidos à análise do estado funcional dos linfócitos T CD4+. Resultados: Encontrou-se que os pacientes com LES apresentaram uma diminuição na quantidade total de células CD4+, um aumento na quantidade de linfócitos T ativados e um aumento na frequência de linfócitos Th17 em comparação com controles saudáveis (HC). As células LTM tinha frequência aumentada em pacientes com LES e houve um aumento na frequência de LTM trifuncionais em pacientes com LES ativo em comparação com aqueles com LES inativo. Curiosamente, as células MTF produziram quantidades maiores de IFN-γ do que os linfócitos T monofuncionais em pacientes e controles. Conclusão: Analisados em conjunto, esses dados indicam a participação dos linfócitos Th17 recentemente ativados e células MTF na fisiopatologia do LES.
Abstract Introduction/Objective: Recent evidence suggests that abnormalities involving Th17 lymphocytes are associated with the pathophysiology of systemic lupus erythematosus (SLE). In addition, multifunctional T cells (MFT), i. e., those producing multiple cytokines simultaneously, are present in the inflammatory milieu and may be implicated in the autoimmune process observed in SLE. In the present study, we aimed to characterize the functional status of CD4+ T cells in SLE by simultaneously determining the concentration of IL-2, IFN-γ and IL-17 in lymphocyte cultures under exogenous and self-antigenic stimuli. Patients and methods: Eighteen patients with active disease, 18 with inactive disease, and 14 healthy controls had functional status of CD4+ T cells analyzed. Results: We found that SLE patients presented a decreased number of total CD4+ cells, an increased number of activated T cells, and an increased frequency of Th17 cells compared to healthy controls (HC). MFT cells had increased frequency in SLE patients and there was an increased frequency of tri-functional MFT in patients with active SLE compared with those with inactive SLE. Interestingly, MTF cells produced larger amounts of IFNγ than mono-functional T cells in patients and controls. Conclusion: Taken together these data indicate the participation of recently activated Th17 cells and MTF cells in the SLE pathophysiology.
Subject(s)
Humans , CD4-Positive T-Lymphocytes/immunology , Th17 Cells/immunology , Lupus Erythematosus, Systemic/physiopathology , Lupus Erythematosus, Systemic/immunology , Lymphocyte Activation , Cytokines , CD4 Lymphocyte Count , Flow CytometryABSTRACT
SummaryIntroduction:aging is associated with several immunologic changes. Regulatory (Treg) and effector T cells are involved in the pathogenesis of infectious, neoplastic, and autoimmune diseases. Little is known about the effects of aging on the frequency and function of these T cell subpopulations.Methods:peripheral blood mononuclear cells (PBMC) were obtained from 26 young (under 44 years old) and 18 elderly (above 80 years old) healthy women. T cell subpopulations were analyzed by flow cytometry.Results:elderly individuals had lower frequency of several activated effector T cell phenotypes as compared with young individuals: CD3+CD4+CD25+ (3.82±1.93 versus 9.53±4.49; p<0.0001); CD3+CD4+CD25+CD127+(2.39±1.19 versus 7.26±3.84; p<0.0001); CD3+CD4+CD25+ (0.41±0.22 versus 1.86±0.85, p<0.0001); and CD3+CD4+CD25highCD127+(0.06±0.038 versus 0.94±0.64, p<0.0001). Treg (CD3+CD4+CD25+CD127øFoxp3+) presented lower frequency in elderly individuals as compared to young adults (0.34±0.18 versus 0.76±0.48; p=0.0004) and its frequency was inversely correlated with age in the whole group (r=-0.439; p=0.013). The elderly group showed higher frequency of two undefined CD25øFoxp3+ phenotypes: CD3+CD4+CD25øFoxp3+(15.05±7.34 versus 1.65±1.71; p<0.0001) and CD3+CD4+CD25øCD127øFoxp3+(13.0±5.52 versus 3.51±2.87; p<0.0001).Conclusions:the altered proportion of different T cell subsets herein documented in healthy elderly women may be relevant to the understanding of the immunologic behavior and disease susceptibility patterns observed in geriatric patients.
ResumoIntrodução:o envelhecimento está associado a diversas alterações imunológicas. Células T reguladoras e efetoras estão envolvidas na patogênese de enfermidades infecciosas, neoplásicas e autoimunes. Pouco se sabe acerca dos efeitos da idade sobre a frequência e a função dessas populações celulares.Métodos:células mononucleares do sangue periférico foram obtidas de participantes saudáveis (26 com idade inferior a 44 anos e 18 acima de 80 anos). As subpopulações celulares foram analisadas por citometria de fluxo.Resultados:o grupo constituído por idosas apresentou menor frequência de vários fenótipos de células T efetoras ativadas em comparação com jovens: CD3+CD4+CD25+ (3,82±1,93 versus 9,53±4,49, p<0,0001); CD3+CD4+ CD25+CD127+ (2,39±1,19 versus7,26±3,84, p<0,0001); CD3+CD4+CD25high(0,41±0,22 versus 1,86±0,85, p<0,0001); CD3+CD4+CD25highCD127+(0,06±0,038 versus 0,94±0,64, p<0,0001). As células T reguladoras CD3+CD4+CD25highCD127øFoxP3+ apresentaram menor frequência em indivíduos idosos em comparação com adultos jovens (0,34±0,18 versus0,76±0,48, p=0,0004) e sua frequência foi inversamente correlacionada com a idade em todo o grupo (r=-0,439; p=0,013). O grupo de idosas apresentou maior frequência de dois fenótipos indefinidos (CD25øFoxP3+), células CD3+CD4+CD25øFoxP3+ (15,05±7,34 versus 1,65±1,71, p<0,0001) e células CD3+CD4+CD25øCD127øFoxP3+(13,0±5,52 versus 3,51±2,87, p<0,0001).Conclusão:as proporções alteradas de diferentes subpopulações de células T em idosas saudáveis contribuem para a compreensão dos padrões de comportamento e suscetibilidade a doenças imunológicas evidenciadas em pacientes geriátricos.
Subject(s)
Adult , Aged, 80 and over , Female , Humans , Young Adult , Aging/immunology , Immunophenotyping , T-Lymphocyte Subsets/immunology , T-Lymphocytes, Regulatory/cytology , Age Factors , Flow Cytometry , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/immunology , T-Lymphocyte Subsets/cytology , T-Lymphocytes, Regulatory/immunologyABSTRACT
Introduction: Vaccination is the main preventive strategy against Yellow Fever (YF), which is a public health concern in Brazil. However, HIV-infected patients might have insufficient knowledge regarding YF, YF prevention, and vaccines in general. Methods: In this questionnaire-based study, data from 158 HIV-infected individuals were addressed in three distinct outpatient clinics in São Paulo. Information was collected on demographic and clinical characteristics, as well as patients' knowledge of vaccines, YF and YF preventive strategies. In addition, individual YF vaccine recommendations and vaccine status were investigated. Results: Although most participants adequately ascertain the vaccine as the main prevention strategy against YF, few participants were aware of the severity and lack of specific treatment for YF. Discrepancy in YF vaccine (patients who should have taken the vaccine, but did not) was observed in 18.8% of participants. Conclusion: YF is an important and preventable public health concern, and these results demonstrate that more information is necessary for the HIV-infected population.
A vacinação é a principal forma de prevenção contra a Febre Amarela (FA), doença de importância em saúde pública no Brasil. Entretanto, pessoas que vivem com HIV possivelmente possuem conhecimentos insuficientes a respeito da FA, suas formas de prevenção e também sobre vacinas de modo geral. Métodos: Neste estudo baseado em questionários de autopreenchimento, avaliamos dados de 158 pacientes infectados por HIV atendidos em três diferentes serviços ambulatoriais do Município de São Paulo. Foram coletados dados demográficos, clínicos, e dados relacionados ao grau de conhecimento a respeito de vacinas, da FA e de suas formas de prevenção. Além disso, avaliamos individualmente a indicação e antecedente de vacinação contra FA. Resultados: Embora a maioria dos participantes tenha identificado corretamente que a vacina é a principal forma de prevenção da FA, poucos tinham conhecimento a respeito da gravidade clínica e ausência de tratamento específico da doença. Discrepância na vacinação (caracterizada quando o participante deveria ter recebido a vacina, mas não a recebeu) foi observada em 18,8% dos casos. Conclusão: A FA é importante agravo em saúde pública, passível de prevenção, e nossos resultados demonstram que são necessárias mais ações de educação voltadas à população de pessoas que vivem com HIV.
Subject(s)
Adolescent , Adult , Female , Humans , Male , Health Knowledge, Attitudes, Practice , HIV Infections , Yellow Fever Vaccine , Yellow Fever/prevention & control , Brazil , Cross-Sectional Studies , Surveys and QuestionnairesABSTRACT
2.2 million adults were newly HIV-infected in 2011, underscoringthe urgent need for new, effective ways to prevent incident infections.1 Recently, the field of HIV prevention has gathered positiveresults from different strategies, among different populations, andwith varying effect sizes, including the treatment of HIV-positivewomen and men in discordant couples,2-4 male circumcision ofHIV-negative men in sub-Saharan Africa,5-7 a HIV vaccine evaluatedin a community-based trial among HIV-negative men andwomen in Thailand,8 the use of vaginal gel formulation of TDFfor HIV prevention in women in South Africa,9 pre-exposureprophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF) oremtricitabine and TDF (TDF-FTC) among HIV-1-serodiscordantheterosexual couples from Kenya and Uganda,10 and PrEP withTDF-FTC among heterosexual men and women in Africa.11,12 Ofthese interventions, PrEP is an attractive policy because it doesnot directly interferes with the sexual intercourse, providing peoplea choice on HIV prevention regardless of cultural, religious, orsocial harnesses.
Subject(s)
AIDS Serodiagnosis , Therapeutics , InfectionsABSTRACT
OBJECTIVES: The purpose of this study was to investigate the association between T cell receptor excision circle levels in peripheral blood mononuclear cells and regulatory T cells that co-express CD25 and Foxp3 in healthy children and adolescents of different ages. MATERIALS AND METHODS: The quantification of signal-joint T-cell receptor excision circle levels in the genomic DNA of peripheral blood mononuclear cells was performed using real-time quantitative PCR. The analysis of CD4, CD8, CD25, and Foxp3 expression was performed using flow cytometry. RESULTS: Ninety-five healthy controls (46 females and 49 males) ranging in age from 1 to 18 years were analyzed. The mean T-cell receptor excision circle count in all individuals was 89.095¡36.790 T-cell receptor excision circles per microgram of DNA. There was an inverse correlation between T-cell receptor excision circles counts and age (r = -0.846; p<0.001) as well as between the proportion of CD4+CD25+Foxp3+ T cells and age (r = -0.467; p = 0.04). In addition, we observed a positive correlation between the amount of CD4+CD25+Foxp3+ T cells and the amount of Tcell receptor excision circles per microgram of DNA in individuals of all ages (r = -0.529; p = 0.02). CONCLUSIONS: In this study, we observed a decrease in the thymic function with age based on the fact that the level of T-cell receptor excision circles in the peripheral blood positively correlated with the proportion of regulatory T cells in healthy children and adolescents. These findings indicate that although T-cell receptor excision circles and regulatory T cells levels decrease with age, homeostasis of the immune system and relative regulatory T cells population levels are maintained in the peripheral blood.
Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Autoimmune Diseases/immunology , Forkhead Transcription Factors/analysis , /analysis , T-Lymphocytes, Regulatory/immunology , Thymus Gland/immunology , Age Factors , /analysis , /analysis , Receptors, Antigen, T-Cell/metabolism , T-Lymphocytes, Regulatory/metabolism , Thymus Gland/metabolismSubject(s)
Humans , AIDS Vaccines , HIV , Infections/transmission , Acquired Immunodeficiency Syndrome/immunologyABSTRACT
O sistema imune sadio deve manter o balanço entre a capacidade de responder a agentes infecciosos e de sustentar a autotolerância. A ausência de resposta adequada submete o indivíduo aos efeitos deletérios da invasão por patógenos, ao passo que o sistema respondendo de modo exacerbado pode gerar respostas inflamatórias prejudiciais. Acreditava-se que os mecanismos de deleção clonal e anergia fossem os mecanismos essenciais no controle de clones de linfócitos T auto-reativos. Apesar das evidências funcionais a favor da existência de células T supressoras, por muitos anos a imunologia falhou em identificar suas características fenotípicas e confirmar sua existência, motivo pelo qual o tema passou por longo período de descrédito. A recente demonstração de diferentes fenótipos de células, agora chamadas células T regulatórias, reintroduziu o paradigma de que a auto-reatividade é ativamente regulada também por subtipos particulares de linfócitos. Este tema é de grande interesse contemporâneo e a literatura está repleta de estudos descrevendo novos subtipos de células regulatórias, bem como a função, o fenótipo e a freqüência em condições fisiológicas e patológicas. Nesse universo, destaca-se o subtipo mais importante de células com função imunorregulatória, conhecido como células T regulatórias naturais (T REGS). Representando cerca de 5 por cento dos linfócitos T CD4 do sangue periférico, são células caracterizadas pela expressão constitutiva das moléculas FOXP3, GITR, CTLA-4 e altos níveis de CD25. As alterações deletérias nesta população resultam o desencadeamento de doenças auto-imunes em camundongos, muito semelhantes às doenças auto-imunes humanas. A presente revisão aborda os conhecimentos básicos sobre as T REGS e seu estudo em doenças reumáticas de classificação auto-imune, abrindo perspectivas para o entendimento dos mecanismos de regulação periférica e sobre a fisiopatologia dessas enfermidades. Apresenta, ainda, a perspectiva de futuras abordagens...
The healthy immune system must keep the delicate balance between the capacity to respond to exogenous antigens and to keep the tolerance to endogenous antigens. In the absence of an adequate response to exogenous agents the individual is subjected to the deleterious effect of the invasion for pathogens. On the other hand, if the immune system responds in an unwary exacerbated way harmful inflammatory consequences may result. Well-established mechanisms of maintaining self-tolerance include clonal deletion and anergy. Despite the functional evidence in favor of the existence of suppressor T cells, for many years immunologists failed to identify the phenotypic characteristics and to confirm the existence of these lymphocytes. The recent demonstration of different phenotypes of cells, now designated regulatory T cells, reintroduced the paradigm of active regulation of auto-reactivity by particular subtypes of lymphocytes. This subject is of great interest in the contemporary literature. It has been shown that excess regulatory function may be associated with increased susceptibility to infectious and neoplastic diseases. On the other hand decreased regulatory function may cause autoimmunity. In fact, several experimental models of diverse autoimmune conditions have been developed by decreasing or abolishing regulatory T cells. Counterpart of this phenomenon has been sought for in several human autoimmune diseases. At this moment it seems that the most important subtype of regulatory cells are the natural regulatory T cells (TREGS), which represent about 5 percent of peripheral blood CD4 T lymphocytes. These cells are characterized by the constitutive expression of FOXP3, GITR, CTLA-4 and high levels of CD25. The present article reviews the basic knowledge on the TREGS and the several studies describing the status and function of these cells in autoimmune rheumatic diseased.
Subject(s)
Humans , Arthritis, Rheumatoid , Autoimmune Diseases , Immune Tolerance , Rheumatic Diseases , T-LymphocytesABSTRACT
OBJECTIVES: The present study aimed to evaluate the dynamics of CD28 and CD57 expression in CD8+ T lymphocytes during cytomegalovirus viremia in bone marrow transplant recipients. METHODS: In a prospective study, blood samples were obtained once weekly once from 33 healthy volunteers and weekly from 33 patients. To evaluate the expression of CD57 and CD28 on CD8+ T lymphocytes, flow cytometry analysis was performed on blood samples for four months after bone marrow transplant, together with cytomegalovirus antigenemia assays. RESULTS: Compared to cytomegalovirus-seronegative healthy subjects, seropositive healthy subjects demonstrated a higher percentage of CD57+ and a lower percentage of CD28+ cells (p<0.05). A linear regression model demonstrated a continuous decrease in CD28+ expression and a continuous increase in CD57+ expression after bone marrow transplant. The occurrence of cytomegalovirus antigenemia was associated with a steep drop in the percentage of CD28+ cells (5.94 percent, p<0.01) and an increase in CD57+ lymphocytes (5.60 percent, p<0.01). This cytomegalovirus-dependent effect was for the most part concentrated in the allogeneic bone marrow transplant patients. The development of acute graft versus host disease, which occurred at an earlier time than antigenemia (day 26 vs. day 56 post- bone marrow transplant), also had an impact on the CD57+ subset, triggering an increase of 4.9 percent in CD57+ lymphocytes (p<0.05). CONCLUSION: We found continuous relative changes in the CD28+ and CD57+ subsets during the first 120 days post- bone marrow transplant, as part of immune system reconstitution and maturation. A clear correlation was observed between the expansion of the CD57+CD28-CD8+ T lymphocyte subpopulation and the occurrence of graft versus host disease and cytomegalovirus viremia.
Subject(s)
Adult , Female , Humans , Male , Young Adult , Antigens, CD/immunology , Bone Marrow Transplantation/immunology , /immunology , Cytomegalovirus Infections/immunology , Graft vs Host Disease/immunology , Viremia/immunology , /immunology , /immunology , /immunology , /virology , Cytomegalovirus Infections/blood , Cytomegalovirus Infections/prevention & control , Graft vs Host Disease/virology , Linear Models , Prospective Studies , Viremia/blood , Viremia/prevention & control , Young AdultABSTRACT
Three HIV-1-seronegative patients with disseminated tuberculosis presented significant depletion of T-cell counts, in CD4+ and/or CD8+ cells, associated with increased expression of activation marker CD38 on CD8+ T-lymphocytes. This finding raises the question of potential mechanisms involved in the activation or loss of T-cells in disseminated tuberculosis.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , /immunology , Lymphocyte Activation/immunology , Mycobacterium tuberculosis/immunology , T-Lymphocytes/immunology , Tuberculosis, Pulmonary/immunology , Case-Control Studies , Lymphocyte Depletion , Mycobacterium tuberculosis/isolation & purification , Severity of Illness Index , Tuberculosis, Pulmonary/diagnosisABSTRACT
An interesting interaction pattern has been found between HIV-1 and GBV-C/HGV, resulting in protection against progression to AIDS. The mechanisms involved in this interaction remain to be clarified. We examined the current knowledge concerning this coinfection and developed hypotheses to explain its effects. A better understanding of this interaction could result in new concepts, which may lead to new strategies to control HIV-1 replication and progression to AIDS.
Subject(s)
Humans , Flaviviridae Infections/complications , GB virus C/immunology , HIV Infections/complications , HIV-1 , Hepatitis, Viral, Human/complications , Disease Progression , Flaviviridae Infections/immunology , HIV Infections/immunology , Hepatitis, Viral, Human/immunologyABSTRACT
Several strategies aim at characterizing the AIDS epidemic in different parts of the world. Among these, the identification of recent HIV-1 infections using the recently described serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion (STARHS) strategy was employed in four testing sites of the City of São Paulo Public Health Department (CSPPHD). Those identified as recently infected were invited to participate in a prospective clinical and laboratory evaluation study. We describe the establishment of the patient identification network and the success in enrolling the participants, as well as their clinical and laboratory characteristics. From May to December 2002, 6,443 persons were tested for HIV in the four participating sites, of whom 384 (5.96 percent) tested HIV-1 positive; 43 (11.2 percent) of them were identified as recently infected. Twenty-two were successfully enrolled in the follow-up study, but three of them did not meet clinical and/or laboratory criteria for recent HIV-1 infection. After these exclusions, the laboratory findings revealed a median CD4+ T lymphocyte count of 585 cells/muL (inter-quartile range 25-75 percent [IQR], 372-754), a CD8+ T lymphocyte count of 886 cells/muL (IQR, 553-1098), a viral load of 11,000 HIV-RNA copies/mL (IQR, 3,650-78,150), log10 of 4.04 (IQR 3.56-4.88). The identification of recent HIV infections is an extremely valuable way to evaluate the spread of the virus in a given population, especially when cohort studies, considered the gold standard method to evaluate incidence, are not available. This work demonstrated that establishing a network to identify such patients is a feasible task, even considering the difficulties in a large, resource-limited country or city.
Subject(s)
Humans , Male , Female , Adult , Aged , Algorithms , HIV Infections/diagnosis , HIV-1 , Information Services , Serologic Tests/methods , Follow-Up Studies , Prospective Studies , RNA, Viral/analysis , Time FactorsABSTRACT
CD4+ and CD8+ T lymphocyte counts, naive and memory/effector CD4+ T subpopulations, and the expression of CD38 on CD8+ T lymphocytes were evaluated in four groups: AIDS patients with tuberculosis (HIV/TB, n=14), HIV-1 infected patients (HIV, n=10), HIV-1 negative patients with tuberculosis (TB, n=20) and healthy controls (CTL, n=17). TB and HIV had fewer CD4+ T cells than CTL, with the lowest values observed in TB/HIV (p<0.001). No difference between groups was observed in the percentage of naive and memory/effector subpopulations in CD4+ T lymphocytes. TB (355 cells/mL) and HIV (517 cells/mL) had diverging effects on CD8+ T cell counts, with a marked depletion observed in HIV/TB (196 cells/mL). TB and HIV up-regulated CD38 expression on CD8+ T cells, a finding also present in TB/HIV. While the decrease of CD4+ T cell counts in HIV/TB may be attributed to HIV and tuberculosis, the decrease of CD8+ T cell counts is likely to be due to tuberculosis
Subject(s)
Humans , Adult , Tuberculosis, Pulmonary , CD4-Positive T-Lymphocytes , T-Lymphocyte Subsets , HIV-1 , AIDS-Related Opportunistic Infections , CD8-Positive T-Lymphocytes , Immunologic Memory , Tuberculosis, Pulmonary , Case-Control Studies , Analysis of Variance , AIDS-Related Opportunistic Infections , CD4 Lymphocyte Count , Antibodies, Monoclonal , Antigens, Surface , Lymphocyte ActivationABSTRACT
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are the causative agents of AIDS. HIV-2 is prevalent at moderate to high rates in West African countries, such as Senegal, Guinea, Gambia, and Cape Verde. Diagnosis of HIV-2 is made with a positive HIV-1/HIV-2 ELISA or simple/rapid assay, followed by one or two confirmatory tests specific for HIV-2. Following CD4+ T cell counts, HIV-2 viral burden and clinical signs and symptoms of immunodeficiency are beneficial in monitoring HIV-2 disease progression. Although non-nucleoside reverse transcriptase inhibitors are ineffective in treating HIV-2, nucleoside reverse transcriptase inhibitors and protease inhibitors can be effective in dual and triple antiretroviral regimens. Their use can decrease HIV-2 viral load, increase CD4+ T cell counts and improve AIDS-related symptoms. HIV-2 resistance to various nucleoside reverse transcriptase inhibitors and protease inhibitors, including zidovudine, lamivudine, ritonavir and indinavir, has been identified in some HIV-2 infected patients on antiretroviral therapy. The knowledge of HIV-2 peculiarities, when compared to HIV-1, is crucial to helping diagnose and guide the clinician in the choice of the initial antiretroviral regimen and for monitoring therapy success
Subject(s)
Humans , Anti-HIV Agents/therapeutic use , Drug Resistance, Viral , HIV Infections/drug therapy , HIV-2 , Nucleosides/therapeutic use , Reverse Transcriptase Inhibitors/therapeutic use , Anti-HIV Agents/pharmacology , Drug Therapy, Combination , HIV Infections/diagnosis , Mutation , Nucleosides/pharmacology , Protease Inhibitors/pharmacology , Protease Inhibitors/therapeutic use , Reverse Transcriptase Inhibitors/pharmacologyABSTRACT
Com a ameaça internacional do bioterrorismo, a varíola voltou a ganhar destaque mundial. Os autores revisam aspectos da varíola e trazem consideraçöes atuais da utilizaçäo do agente como arma biológica. Também apresentam dados dos esforços atuais na produçäo e desenvolvimento de vacinas contra a doença